These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12540592)

  • 1. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.
    Tschritter O; Fritsche A; Thamer C; Haap M; Shirkavand F; Rahe S; Staiger H; Maerker E; Häring H; Stumvoll M
    Diabetes; 2003 Feb; 52(2):239-43. PubMed ID: 12540592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.
    Stefan N; Vozarova B; Funahashi T; Matsuzawa Y; Weyer C; Lindsay RS; Youngren JF; Havel PJ; Pratley RE; Bogardus C; Tataranni PA
    Diabetes; 2002 Jun; 51(6):1884-8. PubMed ID: 12031977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
    Bajaj M; Suraamornkul S; Kashyap S; Cusi K; Mandarino L; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4649-55. PubMed ID: 15356076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.
    Ryan AS; Berman DM; Nicklas BJ; Sinha M; Gingerich RL; Meneilly GS; Egan JM; Elahi D
    Diabetes Care; 2003 Aug; 26(8):2383-8. PubMed ID: 12882866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.
    Weyer C; Funahashi T; Tanaka S; Hotta K; Matsuzawa Y; Pratley RE; Tataranni PA
    J Clin Endocrinol Metab; 2001 May; 86(5):1930-5. PubMed ID: 11344187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
    Yu JG; Javorschi S; Hevener AL; Kruszynska YT; Norman RA; Sinha M; Olefsky JM
    Diabetes; 2002 Oct; 51(10):2968-74. PubMed ID: 12351435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma adiponectin and endogenous glucose production in humans.
    Stefan N; Stumvoll M; Vozarova B; Weyer C; Funahashi T; Matsuzawa Y; Bogardus C; Tataranni PA
    Diabetes Care; 2003 Dec; 26(12):3315-9. PubMed ID: 14633820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Piper P; Hardies LJ; Glass L; Cersosimo E; Pratipanawatr T; Miyazaki Y; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Jan; 89(1):200-6. PubMed ID: 14715850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma adiponectin levels are not associated with fat oxidation in humans.
    Stefan N; Vozarova B; Funahashi T; Matsuzawa Y; Ravussin E; Weyer C; Tataranni PA
    Obes Res; 2002 Oct; 10(10):1016-20. PubMed ID: 12376582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
    Nagi DK; Tracy R; Pratley R
    Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.
    Bacha F; Saad R; Gungor N; Arslanian SA
    Diabetes Care; 2004 Feb; 27(2):547-52. PubMed ID: 14747242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
    Sumner AE; Kushner H; Sherif KD; Tulenko TN; Falkner B; Marsh JB
    Diabetes Care; 1999 Jan; 22(1):71-7. PubMed ID: 10333906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
    Yokoyama H; Emoto M; Mori K; Araki T; Teramura M; Koyama H; Shoji T; Inaba M; Nishizawa Y
    J Clin Endocrinol Metab; 2006 Jan; 91(1):290-4. PubMed ID: 16234307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans.
    Peter A; Kantartzis K; Machann J; Schick F; Staiger H; Machicao F; Schleicher E; Fritsche A; Häring HU; Stefan N
    Diabetes; 2010 Dec; 59(12):3167-73. PubMed ID: 20841609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.
    Yang B; Brown KK; Chen L; Carrick KM; Clifton LG; McNulty JA; Winegar DA; Strum JC; Stimpson SA; Pahel GL
    BMC Pharmacol; 2004 Oct; 4():23. PubMed ID: 15491498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies.
    Baratta R; Amato S; Degano C; Farina MG; Patanè G; Vigneri R; Frittitta L
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2665-71. PubMed ID: 15181039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin in a native Canadian population experiencing rapid epidemiological transition.
    Hanley AJ; Connelly PW; Harris SB; Zinman B
    Diabetes Care; 2003 Dec; 26(12):3219-25. PubMed ID: 14633805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
    Miyazaki Y; Mahankali A; Matsuda M; Glass L; Mahankali S; Ferrannini E; Cusi K; Mandarino LJ; DeFronzo RA
    Diabetes Care; 2001 Apr; 24(4):710-9. PubMed ID: 11315836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.